4-[1-[[6-[[4-(Trifluoromethyl)Phenyl]Methyl]-6-Azaspiro[2.5]Octane-7-Carbonyl]Amino]Cyclopropyl]Benzoic Acid

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

2 Sponsors

1 Countries

Phase II

Phase I/II

Phase II: 1 Phase I/II: 1

Indications tested

Colorectal adenocarcinoma 1

Sponsors using this IMP

Fondazione GONO G.I. 1 Rottapharm Biotech S.r.l. 1

All trials

2 total

Window-of-opportunity umbrella platform trial of short-course pre-operative targeted treatments in patients with molecularly selected and re… Recruiting

2022-501308-90-00 Phase II 1 country Fondazione GONO G.I.
A study to evaluate the safety and efficacy of CR6086 in combination with balstilimab (AGEN2034), in patients with pretreated mismatch-repai… Ended

2024-515446-16-00 Phase I/II 1 country Rottapharm Biotech S.r.l.

Showing 1–2 of 2 trials

← All drugs A–Z